A. Eich

A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease

A. Eich, Veronika S. Urbán, Marek Jutel et al. · COPD Journal of Chronic Obstructive Pulmonary Disease · 2017 · 75 citations · Full text

Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients

Philip E. Silkoff, Michel Laviolette, Dave Singh et al. · Journal of Allergy and Clinical Immunology · 2017 · 69 citations

Asthma, Inflammation, Allergy +10

Asthma characteristics and biomarkers from the Airways Disease Endotyping for Personalized Therapeutics (ADEPT) longitudinal profiling study

Philip E. Silkoff, Irina Strâmbu, Michel Laviolette et al. · Respiratory Research · 2015 · 63 citations · Full text

Efficacy and safety of tezepelumab versus placebo in adults with moderate to very severe chronic obstructive pulmonary disease (COURSE): a randomised, placebo-controlled, phase 2a trial

Dave Singh, Christopher E. Brightling, Klaus F. Rabe et al. · The Lancet Respiratory Medicine · 2024 · 48 citations · Full text

Advanced Lung Disease, Clinical Trials, Tezepelumab Versus Placebo +4

Toll-like receptor 3 blockade in rhinovirus-induced experimental asthma exacerbations: A randomized controlled study

Philip E. Silkoff, Susan Flavin, Robert Gordon et al. · Journal of Allergy and Clinical Immunology · 2017 · 42 citations · Full text

Asthma, Immunology, Antiviral Response +5